-31.0%
MRNA vs SPXL
+49.9%
-80.9%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SPXL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -10.5% | +8.3% | +2.9% |
| 7D | -12.7% | -23.8% | +11.1% | -0.8% |
| 30D | -20.7% | -30.6% | +9.9% | -5.6% |
| 3M | +46.3% | -28.7% | +74.9% | +72.3% |
| 6M | +305.2% | -24.6% | +329.8% | +365.9% |
| YTD | +561.2% | -8.0% | +569.2% | +591.4% |
| 1Y | +772.1% | +4.4% | +767.7% | +763.1% |
| 3Y | +147.0% | +126.7% | +20.2% | +65.0% |
| All | -31.0% | +49.9% | -80.9% | -53.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXL.
Daily Out/Under-Performance
Portfolio return minus SPXL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SPXL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling